Publication | Open Access

GM-CSF DNA: An adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine

VaccinationGm-csf DnaVaccine DevelopmentImmunologyVirologyVaccine DesignImmunotherapyMedicineVaccine ResearchHigher Avidity IggRectal Iga